WHO-Supported Study Shows ‘Strong Evidence’ HPV Vaccines Effective In Preventing Cervical Cancer, Should Be Expanded
CNBC: WHO study finds ‘strong evidence’ HPV vaccine can prevent cervical cancer
“International researchers say there’s ‘strong evidence’ the HPV vaccine prevents cervical cancer and should be expanded to boys and adults, according to a World Health Organization study published Wednesday in The Lancet…” (LaVito, 6/26).
Reuters: Study shows major real-world impact of cervical cancer vaccines
“…[The] team gathered data on 60 million people over eight years from 65 separate studies conducted in 14 countries and pooled it to assess the vaccines’ impact. They found that the two HPV types that cause 70% of cervical cancers — known as HPV 16 and HPV 18 — were significantly reduced after vaccination, with an 83% decline in infections in girls aged 13 to 19 and 66% drop in women aged 20 to 24 after five to eight years of vaccination…” (Kelland, 6/26).
The Telegraph: Cervical cancer could be eliminated within decades, scientists say
“…The research, funded by the World Health Organization (WHO) and led by Canadian researchers, examined progress in 14 countries … Researcher Professor Marc Brisson of Laval University, Canada said: ‘Because of our finding, we believe the WHO call for action to eliminate cervical cancer may be possible in many countries if sufficient vaccination coverage can be achieved.’ He said that this should be achieved ‘in decades’ if uptake remains high, with a ‘substantial reduction’ in cases of cervical cancer in the next 10 years. Elimination of disease would mean fewer than four cases per 100,000 people, under WHO classifications…” (Donnelly, 6/26).